Reversible Epstein-Barr Virus-Negative Lymphadenopathy and Bone Marrow Involved by Hodgkin's Lymphoma in a Rheumatoid Arthritis Patient Undergoing Long-term Treatment with Low-Dose Methotrexate: A Case Report and Review of the Literature

2006 ◽  
Vol 83 (1) ◽  
pp. 47-50 ◽  
Author(s):  
Annika M. Svensson ◽  
Erica R. Jacobson ◽  
David Ospina ◽  
Barbara H. Tindle
Keyword(s):  
Rheumatoid Arthritis ◽  
Epstein Barr Virus ◽  
Low Dose ◽  
Term Treatment ◽  
Review Of The Literature ◽  
Barr Virus ◽  
Dose Methotrexate ◽  
Long Term Treatment ◽  
Epstein Barr

scholarly journals Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study

PLoS ONE ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. e0171623 ◽  
Author(s):  
Nathalie Balandraud ◽  
Gaetan Texier ◽  
Emmanuel Massy ◽  
Olivier Muis-Pistor ◽  
Marielle Martin ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Retrospective Study ◽  
Epstein Barr Virus ◽  
Term Treatment ◽  
Virus Load ◽  
Barr Virus ◽  
Long Term Treatment ◽  
Epstein Barr

Long-term treatment with methotrexate or tumor necrosis factor α inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis

2007 ◽  
Vol 57 (5) ◽  
pp. 762-767 ◽  
Author(s):  
Nathalie Balandraud ◽  
Sandrine Guis ◽  
Jean Baptiste Meynard ◽  
Isabelle Auger ◽  
Jean Roudier ◽  
...  
Keyword(s):  
Tumor Necrosis ◽  
Epstein Barr Virus ◽  
Tumor Necrosis Factor Α ◽  
Term Treatment ◽  
Barr Virus ◽  
Long Term Treatment ◽  
Epstein Barr ◽  
Factor Α ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document